HIV/AIDS Drug Resistance: Research

Overview | HIV Mutations | Resistance Risk | Resistance Testing

Overview

Transmitted Antiretroviral Drug Resistance Holds Steady at 16% (Video) (March 25, 2013)
From HIVandHepatitis.com
California: Studying Drug-Resistant HIV in Los Angeles County (March 19, 2013)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Eradication/Cure, Prevention, Novel Strategies for Administration of PrEP (Delivery Alternatives), Antiretroviral Therapy/Drug Resistance/New Drugs/Comorbidities (March 17, 2013)
From National AIDS Treatment Advocacy Project
Resistance to Darunavir Falling Since Approval of the Protease Inhibitor in 2006 (March 11, 2013)
From National AIDS Treatment Advocacy Project
Can People With Resistant HIV Omit NRTIs When Switching From a Failing Regimen? (March 7, 2013)
From aidsmap.com
Can People With Resistant HIV Omit NRTIs When Switching to a New Regimen? (Video) (March 7, 2013)
From HIVandHepatitis.com
Wide U.S. Study Finds 16% With Newly Diagnosed HIV Carry Resistant Virus (March 6, 2013)
From National AIDS Treatment Advocacy Project
Transmission of Resistant HIV Steady (March 6, 2013)
From MedPage Today
Dolutegravir: Integrase Resistance and the Impact of the Background Regimen (November/December 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
Resistance in Infants and Children Receiving ART in South Africa (November/December 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base

VIEW ALL ARTICLES

Resistance Risk

Resistance Rates and Patterns Similar With Extended- and Immediate-Release Nevirapine (September 21, 2011)
From National AIDS Treatment Advocacy Project
Some Children With HIV Grow Resistant to Drugs, Says Study (April 25, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Is HIV Drug Resistance Spreading? Early Warning Signals Say "Yes" (March 2, 2011)
From aidsmap.com
New Data From PrEP Study Shed Light on Adherence, Bone Mineral Loss and Resistance (March 2, 2011)
From aidsmap.com
IRIN/PlusNews Examines Threat of HIV Drug-Resistance in Africa (September 13, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
Protease Inhibitor to Raltegravir Switch Maintains Viral Suppression, but NRTI Resistance Lowers Efficacy (July 22, 2010)
From aidsmap.com
Researchers Develop Questions to Determine Risk of HIV/AIDS Drug Resistance (May 19, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Sudden Drop Observed in Transmitted HIV Drug Resistance Among Cohort of Recently Infected San Francisco Patients (February 10, 2009)
Vivek Jain, M.D., presents data from a cohort of 266 patients with acute and early HIV infection, among whom a sudden drop in the prevalence of transmitted HIV drug resistance occurred in 2008 -- dramatically reversing a general upward trend over the previous four years.
In The 16th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
Early Archiving and Predominance of Nonnucleoside Reverse Transcriptase Inhibitor¨CResistant HIV-1 among Recently Infected Infants Born in the United States (May 15, 2007)
In Journal of Infectious Diseases
Drug-Resistant HIV Transmission Is Falling Steadily in United Kingdom (May 1, 2007)
From aidsmap.com

VIEW ALL ARTICLES

MOST VIEWED ARTICLES

	HIV Management Today: Mental Health & HIV, the Uncharted Territory
	Danish Study Targets HIV Reservoir, in Latest Search for HIV Cure
	10 Top Studies Whose Impact Will Last Well Beyond CROI 2013
	CROI 2013: Women's Issues in HIV Research (Video)
	PrEP Failures and Successes: One Study Whose Impact Will Last Well Beyond CROI 2013
	HIV Opportunistic Infection Guidelines Updated

More Most Viewed Articles

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.